4mail copy

Chairman:
Scientific Committee:
17:30-17:45
17:45-19:45
17:45-18:15
18:15-18:45
18:45-19:15
19:15-19:30
19:30-19:45
Prof. Mordechai Kramer- Respiratory Division, Rabin MC
Prof. Mordechai Kramer
Dr. Yochai Adir
Prof. David Shitrit Prof. Neville Berckman
Dr. Amnon Ariel
Welcome, overview and objectives
Dr. Amnon Ariel, Chairman of the Israel society of Pulmonology, Respiratory Division
Prof. Mordechai Kramer, Department of Respiratory Medicine, Rabin MC
Introduction to ILD
Moderated by Prof. Neville Berkman, Department of Respiratory Medicine, Hadassah MC
Dr. Amnon Ariel, Respiratory Medicine Department, Ha'emek MC
The role of HRCT in the diagnosis of ILD
Dr. Naama Bogot, Cardio-Thoracic imagine department, Shaarei Tzedek MC
Interstitial diseases- Biopsies- to whom and when
Prof. Athol Wells, Department of Respiratory Medicine, Royal Brompton, England
ILD in CTD- Case discussion
Dr. Yochai Adir, Department of Respiratory Medicine, Carmel MC, Israel
19:45
21:00
Discussion
IPF registry
Prof. Martina Vasaková, Department of Respiratory Medicine, Thomayer Hospital Prague, Czech Republic
Dinner
Social Program
08:30-10:30
IPF- Pathology, radiology and diagnosis
08:30-09:00
09:00-09:30
09:30-09:45
09:45-10:15
10:15-10:45
10:45-12:20
10:45-11:30
11:30-12:00
12:00-12:20
12:20-12:30
12:30-13:30
Moderated by Prof. Gabriel Izbicki, Chairman Pulmonary Department, Shaare Zedek Medical Center
Dr. Israel Priel, Department of Respiratory Medicine, Wolfson MC
Pathogenesis and natural history of IPF
Prof. Luca Richeldi, Department of Respiratory Medicine, University of Southampton, UK
Idiopathic Pulmonary Fibrosis: HRCT for diagnosis, predicting prognosis and staging
Prof. Claus Peter Heussel, ThoraxClinic, University of Heidelberg,Germany
Discussion and Q&A
The combined pulmonary fibrosis and emphysema syndrome - Sponserd by TEVA
Prof. Neville Berkman- Department of Respiratory Medicine, Hadassah MC
Refreshments
IPF- Treatments
Moderated by Prof. Refael Breuer, Department of Respiratory Medicine, Hadassah MC
Dr. Gershon Fink, Department of Respiratory Medicine, Kaplan MC
What have we learned from recent clinical trials in IPF - Empirical Comparison of Nintedanib and Pirfenidone
Prof. Luca Richeldi, Department of Respiratory Medicine, University of Southampton, UK
Impact of the latest IPF treatment trials on the future management of interstitial lung disease IPF
Prof. Athol Wells, Department of Respiratory Medicine, Royal Brompton, England
Transplantation in IPF patients
Prof. Mordechai Kramer, Respiratory Division, Rabin MC, Israel
Break
IPF MEETING
13:30-13:45
13:45
18:00-21:00
21:00
Case discussion
Moderated by Prof. David Shitrit, Department of Respiratory Medicine, Meir MC
Closing remarks - Prof. Mordechai Kramer
Lunch
Dinner
Social Program
IPF MEETING
IPF MEETING
10:00-10:30
10:30-10:45
13:00-15:00
18:00
Pipeline development at Boehringer-Ingelheim
Dr. Markus Hammer, Managing Director; Boehringer Ingelheim Switzerland
Q&A
Lunch
Leaving rooms
The social events are the sole initiative of the Israel Pulmonology
Association and are being financed solely by the association